| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 7 3360-3367, Copyright © 1995 by American Association of Immunologists
ARTICLES |
JC Hurtado, SH Kim, KE Pollok, ZH Lee and BS Kwon
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis 46202, USA.
The expression of the murine T cell Ag 4-1BB, a member of the TNF-R family, is induced by T cell activation. Previously, we and others had shown that signaling through 4-1BB enhanced proliferative T cell responses. To investigate a potential role for the interaction of 4-1BB with its ligand (4-1BBL) in T cell activation, we studied the ability of a soluble chimera of 4-1BB (4-1BBFc) to interfere with proliferative responses and cytokine production in models of activation dependent in intercellular interactions. The potential blocking effect of 4-1BBFc was compared with that of the chimeric molecule CTLA-4Ig, a reagent known to interfere with the interaction of CD28 (and/or CTLA-4) with B7 costimulatory receptors. In this study, we report that 4-1BBFc partially blocked both the activation of unfractionated splenocytes triggered by soluble anti-CD3 (anti-CD3s), and the more physiologically relevant responses to alloantigen. In addition, we show that both chimeric molecules partially blocked proliferative responses and IL-2 secretion by highly purified resting T cells activated with anti-CD3s in the presence of fixed accessory cells that express B7 receptors and 4-1BBL. Furthermore, in this model system, the blocking capacity of 4- 1BBFc and CTLA-4Ig appears to correlate with the relative expression of their respective cognate receptors (4-1BBL and B7) on the accessory cell. Simultaneous addition of both blocking reagents produced an additive effect in the model systems studied.
This article has been cited by other articles:
|
|
 |
|
  K. H. Yi, H. Nechushtan, W. J. Bowers, G. R. Walker, Y. Zhang, D. G. Pham, E. R. Podack, H. J. Federoff, K. A. Tolba, and J. D. Rosenblatt Adoptively Transferred Tumor-Specific T Cells Stimulated Ex vivo Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity In vivo Cancer Res., October 15, 2007; 67(20): 10027 - 10037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, S. Yang, Z. Ye, J. Jaffar, Y. Zhou, E. Cutter, A. Lieber, I. Hellstrom, and K. E. Hellstrom Tumor Cells Expressing Anti-CD137 scFv Induce a Tumor-Destructive Environment Cancer Res., March 1, 2007; 67(5): 2339 - 2344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Toennies, J. M. Green, and R. H. Arch Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms J. Leukoc. Biol., February 1, 2004; 75(2): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wiethe, K. Dittmar, T. Doan, W. Lindenmaier, and R. Tindle Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-{kappa}B (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen J. Immunol., October 15, 2003; 171(8): 4121 - 4130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kimachi, K. Sugie, and H. M. Grey Effector T cells have a lower ligand affinity threshold for activation than naive T cells Int. Immunol., July 1, 2003; 15(7): 885 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Totsuka, T. Kanai, K. Uraushihara, R. Iiyama, M. Yamazaki, H. Akiba, H. Yagita, K. Okumura, and M. Watanabe Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G595 - G603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wiethe, K. Dittmar, T. Doan, W. Lindenmaier, and R. Tindle Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen J. Immunol., March 15, 2003; 170(6): 2912 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Q. Wu, A. Q. Khan, Y. Shen, K. M. Wolcott, W. Dawicki, T. H. Watts, R. S. Mittler, and C. M. Snapper 4-1BB (CD137) Differentially Regulates Murine In Vivo Protein- and Polysaccharide-Specific Immunoglobulin Isotype Responses to Streptococcus pneumoniae Infect. Immun., January 1, 2003; 71(1): 196 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Diehl, G. J. D. van Mierlo, A. T. den Boer, E. van der Voort, M. Fransen, L. van Bostelen, P. Krimpenfort, C. J. M. Melief, R. Mittler, R. E. M. Toes, et al. In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway J. Immunol., April 15, 2002; 168(8): 3755 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Futagawa, H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and K. Okumura Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells Int. Immunol., March 1, 2002; 14(3): 275 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Yamada, A. D. Salama, and M. H. Sayegh The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575. [Full Text] [PDF]
|
|
|
|
|
|
M. Kelleher and P. C. L. Beverley Lipopolysaccharide Modulation of Dendritic Cells Is Insufficient to Mature Dendritic Cells to Generate CTLs from Naive Polyclonal CD8+ T Cells In Vitro, Whereas CD40 Ligation Is Essential J. Immunol., December 1, 2001; 167(11): 6247 - 6255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nozawa, J. Ohata, J. Sakurai, H. Hashimoto, H. Miyajima, H. Yagita, K. Okumura, and M. Azuma Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases J. Immunol., November 1, 2001; 167(9): 4981 - 4986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Ndhlovu, N. Ishii, K. Murata, T. Sato, and K. Sugamura Critical Involvement of OX40 Ligand Signals in the T Cell Priming Events During Experimental Autoimmune Encephalomyelitis J. Immunol., September 1, 2001; 167(5): 2991 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Blazar, B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon, and P. A. Taylor Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients J. Immunol., March 1, 2001; 166(5): 3174 - 3183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Salih, S. G. Kosowski, V. F. Haluska, G. C. Starling, D. T. Loo, F. Lee, A. A. Aruffo, P. A. Trail, and P. A. Kiener Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma Cells J. Immunol., September 1, 2000; 165(5): 2903 - 2910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Martinet, V. Ermekova, J. Q. Qiao, B. Sauter, J. Mandeli, L. Chen, and S.-H. Chen Immunomodulatory Gene Therapy With Interleukin 12 and 4-1BB Ligand: Long- Term Remission of Liver Metastases in a Mouse Model J Natl Cancer Inst, June 7, 2000; 92(11): 931 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Tan, J. K. Whitmire, K. Murali-Krishna, R. Ahmed, J. D. Altman, R. S. Mittler, A. Sette, T. C. Pearson, and C. P. Larsen 4-1BB Costimulation Is Required for Protective Anti-Viral Immunity After Peptide Vaccination J. Immunol., March 1, 2000; 164(5): 2320 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Mittler, T. S. Bailey, K. Klussman, M. D. Trailsmith, and M. K. Hoffmann Anti-4-1BB Monoclonal Antibodies Abrogate T Cell-dependent Humoral Immune Responses In Vivo through the Induction of Helper T Cell Anergy J. Exp. Med., November 15, 1999; 190(10): 1535 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Tan, J. K. Whitmire, R. Ahmed, T. C. Pearson, and C. P. Larsen 4-1BB Ligand, a Member of the TNF Family, Is Important for the Generation of Antiviral CD8 T Cell Responses J. Immunol., November 1, 1999; 163(9): 4859 - 4868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-a. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein 4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine J. Immunol., April 15, 1999; 162(8): 5003 - 5010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gramaglia, A. D. Weinberg, M. Lemon, and M. Croft Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses J. Immunol., December 15, 1998; 161(12): 6510 - 6517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Arch, R. W. Gedrich, and C. B. Thompson Tumor necrosis factor receptor-associated factors (TRAFs)---a family of adapter proteins that regulates life and death Genes & Dev., September 15, 1998; 12(18): 2821 - 2830. [Full Text]
|
|
|
|
|
|
J. A. Harrop, M. Reddy, K. Dede, M. Brigham-Burke, S. Lyn, K. B. Tan, C. Silverman, C. Eichman, R. DiPrinzio, J. Spampanato, et al. Antibodies to TR2 (Herpesvirus Entry Mediator), a New Member of the TNF Receptor Superfamily, Block T Cell Proliferation, Expression of Activation Markers, and Production of Cytokines J. Immunol., August 15, 1998; 161(4): 1786 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Saoulli, S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, et al. CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand J. Exp. Med., June 1, 1998; 187(11): 1849 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Zuckerman, L. Pullen, and J. Miller Functional Consequences of Costimulation by ICAM-1 on IL-2 Gene Expression and T Cell Activation J. Immunol., April 1, 1998; 160(7): 3259 - 3268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. A. a. C. B. Thompson 4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor kappa B Mol. Cell. Biol., January 1, 1998; 18(1): 558 - 565. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Nocentini, L. Giunchi, S. Ronchetti, L. T. Krausz, A. Bartoli, R. Moraca, G. Migliorati, and C. Riccardi A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis PNAS, June 10, 1997; 94(12): 6216 - 6221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Loo, N. J. Chalupny, J. Bajorath, W. W. Shuford, R. S. Mittler, and A. Aruffo Analysis of 4-1BBL and Laminin Binding to Murine 4-1BB, a Member of the Tumor Necrosis Factor Receptor Superfamily, and Comparison with Human 4-1BB J. Biol. Chem., March 7, 1997; 272(10): 6448 - 6456. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
